Esketamine Combined with Dexmedetomidine to reduce Visceral Pain During elective Cesarean Section Under Combined Spinal-Epidural Anesthesia: A double-Blind Randomized Controlled Study
- PMID: 38911034
- PMCID: PMC11193401
- DOI: 10.2147/DDDT.S460924
Esketamine Combined with Dexmedetomidine to reduce Visceral Pain During elective Cesarean Section Under Combined Spinal-Epidural Anesthesia: A double-Blind Randomized Controlled Study
Abstract
Purpose: We aimed to evaluate the effect of intravenous esketamine combined with dexmedetomidine as supplemental analgesia in reducing intraoperative visceral pain during elective cesarean section under combined spinal-epidural anesthesia (CSEA).
Patients and methods: A total of 269 parturients scheduled for elective cesarean section under CSEA between May 2023 and August 2023 were assessed. The parturients were randomly allocated to receiving either intravenous infusion of 0.3-mg/kg esketamine combined with 0.5-μg/kg dexmedetomidine (group ED, n=76), 0.5-μg/kg dexmedetomidine (group D, n=76), or normal saline (group C, n=76) after umbilical cord clamping. The primary outcome was intraoperative visceral pain. Secondary outcomes included the visual analog scale (VAS) score for pain evaluation and other intraoperative complications.
Results: The incidence of visceral pain was lower in group ED [9 (12.7%)] than in group D [32 (43.8%)] and group C [36 (48.6%), P <0.0001]. The VAS score was also lower in group ED when exploring abdominal cavity [0 (0), P <0.0001] and suturing the muscle layer [0 (0), P =0.036]. The mean arterial pressure was higher in group D [83 (9) mmHg] and group ED [81 (11) mmHg] than in group C [75 (10) mmHg, P <0.0001] after solution infusion. The heart rate after infusion of the solution was lower in group D [80 (12) bpm] than in group C [86 (14) bpm] and group ED [85 (12) bpm, P = 0.016]. The incidence of transient neurologic or mental symptoms was higher in group ED compared to group C and group D (76.1% vs 18.9% vs 23.3%, P<0.0001).
Conclusion: During cesarean section, 0.3-mg/kg esketamine combined with 0.5-μg/kg dexmedetomidine can alleviate visceral traction pain and provide stable hemodynamics. Parturients receiving this regimen may experience transient neurologic or mental symptoms that can spontaneously resolve at the end of the surgery.
Keywords: CSEA; cesarean section; dexmedetomidine; esketamine; visceral pain.
Plain language summary
Some parturients endure experience indescribable pain and discomfort during fetal delivery. Esketamine combined with dexmedetomidine can alleviate this pain during cesarean section under combined spinal-epidural anesthesia. However, after intravenous injection of esketamine and dexmedetomidine, the parturients may experience nightmares, dizziness, hallucinations, and drowsiness, etc.
© 2024 Yang et al.
Conflict of interest statement
The authors report no conflicts of interest in this work.
Figures



Similar articles
-
The dose response of sufentanil as an adjuvant to ropivacaine in cesarean section for relief from somato-visceral pain under epidural anesthesia in parturients with scarred uterus.Medicine (Baltimore). 2018 Sep;97(38):e12404. doi: 10.1097/MD.0000000000012404. Medicine (Baltimore). 2018. PMID: 30235712 Free PMC article. Clinical Trial.
-
Effect of mini-dose epidural dexmedetomidine in elective cesarean section using combined spinal-epidural anesthesia: a randomized double-blinded controlled study.J Anesth. 2015 Oct;29(5):708-14. doi: 10.1007/s00540-015-2027-7. Epub 2015 May 26. J Anesth. 2015. PMID: 26006222 Clinical Trial.
-
Impact of Intraoperative Infusion and Postoperative PCIA of Dexmedetomidine on Early Breastfeeding After Elective Cesarean Section: A Randomized Double-Blind Controlled Trial.Drug Des Devel Ther. 2020 Mar 11;14:1083-1093. doi: 10.2147/DDDT.S241153. eCollection 2020. Drug Des Devel Ther. 2020. PMID: 32210537 Free PMC article. Clinical Trial.
-
Effects of perioperative application of esketamine on postpartum depression in cesarean section: A systematic review and meta-analysis.Medicine (Baltimore). 2024 Jul 5;103(27):e38821. doi: 10.1097/MD.0000000000038821. Medicine (Baltimore). 2024. PMID: 38968456 Free PMC article.
-
Effects of ketamine and esketamine on preventing postpartum depression after cesarean delivery: A meta-analysis.J Affect Disord. 2024 Apr 15;351:720-728. doi: 10.1016/j.jad.2024.01.202. Epub 2024 Jan 28. J Affect Disord. 2024. PMID: 38286233 Review.
Cited by
-
Effect of esketamine on reducing postpartum pain and depression.World J Clin Cases. 2025 Mar 6;13(7):100422. doi: 10.12998/wjcc.v13.i7.100422. World J Clin Cases. 2025. PMID: 40051793 Free PMC article.
-
The Effects of Low-Dose Esketamine Combined with Paravertebral Block on Postoperative Hyperalgesia and Enhanced Recovery in Non-Intubated Video-Assisted Thoracic Surgery: A Randomized Controlled Trial.Drug Des Devel Ther. 2025 Aug 15;19:7033-7043. doi: 10.2147/DDDT.S531414. eCollection 2025. Drug Des Devel Ther. 2025. PMID: 40837277 Free PMC article. Clinical Trial.
-
Assessing the Experience and Management of Acute Post-Operative Pain from Caesarean Delivery: A Multi-Centre Cohort Study.J Clin Med. 2025 Jun 30;14(13):4638. doi: 10.3390/jcm14134638. J Clin Med. 2025. PMID: 40649012 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical